This site is intended for healthcare professionals only
LoginRegister
OPPI appoints Bhushan Akshikar as PresidentOPPI appoints Bhushan Akshikar as President
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon partners with Tabuk Pharma to commercialize GLP -1 products in Middle East region
Pfizer INDovation Awards Grants of over Rs 8 Cr to 14 Indian Startups to Drive Next-Gen Healthcare InnovationConduct Active Surveillance Study: CDSCO Panel Tells Pfizer on Abrocitinib tablets
CDSCO Flags 7 Batches of Popular Medicines as Purportedly Spurious in December5 formulations declared as spurious including Sun Pharma's Ursocol 300, Glenmark's Telma H
Dr Reddys Russia Arm Slapped Rs 2.45 Cr VAT PenaltyMexican drug regulator imposes Rs 28 lakh penalty on Dr Reddy's Labs
GST Department Launches Search, Inspection at Ciplas Maharashtra FacilitiesCipla UK arm inks pact to purchase 6.9124 percent stake in Cipla Jiangsu Pharma
Piramal Pharma targets to be over USD 2 billion firm by FY30, says Chairperson Nandini PiramalPiramal Pharma targets to be over USD 2 billion firm by FY30, says Chairperson Nandini Piramal
Intas PharmaIntas Pharma, Henlius receive positive CHMP opinion for Hetronifly in European markets as first line...
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresUSFDA completes audit at Jubilant HollisterStier 2 Washington facilities
Torsemide, Dapagliflozin FDC not rational: CDSCO Panel Rejects Syngenes Proposal for BA/BE studyTorsemide, Dapagliflozin FDC not rational: CDSCO Panel Rejects Syngene's Proposal for BA/BE study
Eli Lilly Announces USD 3.5 Billion US Manufacturing Facility for Next-Gen Obesity DrugsEli Lilly Kisunla approved in Japan for early Symptomatic Alzheimer's disease
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon Biologics announces New Dermatology data to be presented at EADV Congress 2024
X